Cefixime Trihydrate
Also known as: Suprax, Cefix, Taxime, Mahacef, Zifi
CAS Number: 125110-14-7
3rd generation cephalosporin — oral
Pharmacopeia Standards
Mechanism of Action
Third-generation oral cephalosporin with enhanced stability against beta-lactamases compared to first and second-generation agents. Binds PBP-3. Highly active against H. influenzae (including beta-lactamase strains), Moraxella catarrhalis, Neisseria gonorrhoeae, and Enterobacteriaceae. Poor staphylococcal coverage.
Technical Specifications
| Generic / INN Name | Cefixime Trihydrate |
| CAS Registry Number | 125110-14-7 |
| Molecular Formula | C16H15N5O7S2·3H2O |
| Molecular Weight | 507.51 g/mol |
| Typical Purity | 97.5–102.0% (anhydrous basis) |
| Storage Conditions | Store below 30°C, protected from light and moisture |
| Shelf Life | 36 months from date of manufacture |
| Category | Cephalosporins |
Specifications are indicative and intended for sourcing reference only. Always confirm against the supplier's Certificate of Analysis and the applicable pharmacopeial monograph before issuing a purchase specification.
Typical Applications
Uncomplicated gonorrhea (first-line, single 400mg dose), typhoid fever (part of regimen in some guidelines), upper and lower respiratory tract infections, urinary tract infections, pharyngitis, acute otitis media. High use in India and developing markets as step-down parenteral-to-oral therapy.
Manufacturers (8+)
View all →India
India
India
India
Do you manufacture Cefixime Trihydrate? Add your free listing and reach global buyers.
Add listing — FreeCan you supply Cefixime Trihydrate? List as an authorised distributor or export house.
Register as traderEarn commission by connecting buyers with verified API suppliers. Free to join.
Become an agent